Childrens Hospital of Los Angeles

Childrens Hospital of Los Angeles was paid $136.95M by Medicaid between Jan 2018 and Dec 2024, across 602 billing codes. Its largest line is 0123, — 16% of everything it billed.

33Billing provider infoCHILDRENS HOSPITAL OF LOS ANGELES
LOS ANGELES, CA 90027

33aNPI1124073366assigned 05/24/2006

33bProvider typeUrgent Care Clinic/Center

28Total paid$136.95M

24GClaims2,945,648

24DCodes billed602

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Urgent Care Clinic/Center providers in California

Rank by total paid#1 of 284

Median peer was paid$147K

This provider vs. median929×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	460,880	$17.20M
2019	440,824	$17.91M
2020	346,443	$12.87M
2021	386,369	$14.56M
2022	371,136	$18.19M
2023	497,533	$29.90M
2024incomplete	442,463	$26.31M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0123		16%	3,159	3,050	$21.92M
0450	Emergency room services	8.6%	216,286	200,698	$11.84M
Z7500		6.3%	256,280	235,390	$8.67M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	5.0%	8,140	7,563	$6.79M
Z6020		3.8%	19,924	1,756	$5.16M
0636		2.7%	7,816	7,249	$3.67M
70551	Magnetic resonance imaging, brain; without contrast material	2.3%	7,479	7,108	$3.09M
Z4300		2.2%	29,438	25,786	$3.03M
95782		1.8%	2,968	2,930	$2.53M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.4%	25,421	24,113	$1.96M
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.2%	26,961	22,965	$1.69M
P9016	Red blood cells, leukocytes reduced, each unit	1.2%	3,013	2,384	$1.60M

590 more codes

0360		1.1%	9,861	$1.57M
0515		1.0%	125,695	$1.42M
Z4307		1.0%	37,497	$1.42M
Z7610		<1%	103,200	$1.25M
99199	Unlisted special service, procedure or report	<1%	34,808	$1.24M
80053	Comprehensive metabolic panel	<1%	103,996	$1.24M
Z4308		<1%	17,572	$1.17M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,739	$1.12M
Z4301		<1%	30,596	$1.11M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	3,403	$1.10M
87799		<1%	16,428	$1.10M
Z4303		<1%	25,075	$1.09M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	4,453	$1.08M
J0490	Injection, belimumab, 10 mg	<1%	617	$1.08M
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	3,910	$1.03M
Z4304		<1%	13,337	$1.03M
93975		<1%	5,654	$962K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,893	$942K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	5,449	$929K
Z7502		<1%	24,659	$911K
72141		<1%	1,684	$884K
93325		<1%	6,910	$874K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	12,984	$835K
J3490	Unclassified drugs	<1%	57,117	$813K
72146		<1%	1,521	$807K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	9,166	$785K
0270		<1%	74,206	$784K
Z4311		<1%	52,562	$748K
87497		<1%	15,050	$718K
76770		<1%	9,217	$694K
71046	Radiologic examination, chest; 2 views	<1%	20,823	$669K
72156		<1%	645	$634K
Z4310		<1%	44,290	$607K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	74,434	$599K
97799		<1%	17,694	$597K
0760		<1%	26,240	$570K
Z7506		<1%	4,245	$567K
70450	Computed tomography, head or brain; without contrast material	<1%	3,634	$545K
X4303		<1%	7,855	$502K
72158		<1%	506	$499K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,845	$494K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	22,169	$483K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	237	$477K
72157		<1%	479	$455K
Q3014	Telehealth originating site facility fee	<1%	20,403	$449K
93320		<1%	5,497	$443K
97139		<1%	14,213	$439K
99283	Emergency room visit (moderate)	<1%	2,627	$414K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	12,073	$412K
X4500		<1%	4,327	$406K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	16,264	$382K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,193	$369K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	9,354	$358K
Z5406		<1%	18,184	$345K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	6,633	$343K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	6,131	$327K
70543		<1%	1,105	$320K
83036	Hemoglobin; glycosylated (A1C)	<1%	25,614	$314K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	201	$311K
94729		<1%	6,313	$304K
72142		<1%	431	$300K
X3908		<1%	8,901	$294K
0761		<1%	11,653	$289K
92587		<1%	6,637	$283K
94726		<1%	6,370	$279K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	10,596	$272K
84443	Thyroid stimulating hormone (TSH)	<1%	15,864	$272K
74183		<1%	840	$263K
99213	Doctor's office visit, returning patient (routine)	<1%	814	$260K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	7,411	$254K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,246	$249K
80197		<1%	16,382	$249K
J2704	Injection, propofol, 10 mg	<1%	13,072	$246K
J2997	Injection, alteplase recombinant, 1 mg	<1%	2,848	$244K
96450		<1%	873	$236K
96375	Therapeutic injection; each additional sequential IV push	<1%	7,162	$231K
72149		<1%	340	$230K
72147		<1%	339	$230K
72197		<1%	758	$229K
0710		<1%	9,054	$227K
95812		<1%	5,203	$220K
X4530		<1%	4,606	$217K
94642		<1%	1,240	$217K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	157	$204K
Z4312		<1%	15,854	$202K
74019		<1%	6,673	$200K
85027		<1%	29,212	$198K
99234		<1%	2,746	$192K
T1014	Telehealth transmission, per minute, professional services bill separately	<1%	29,513	$183K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	153	$180K
X4110		<1%	5,967	$179K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	700	$178K
X3920		<1%	3,463	$172K
83735		<1%	23,319	$172K
92582		<1%	4,362	$168K
86945		<1%	3,049	$160K
97802		<1%	3,266	$160K
87086	Culture, bacterial; quantitative colony count, urine	<1%	19,368	$158K
84439		<1%	16,152	$150K
X3910		<1%	7,884	$149K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	12,793	$145K
84100		<1%	26,696	$142K
0127		<1%	14	$142K
83970		<1%	3,070	$139K
92567		<1%	5,184	$136K
X4301		<1%	1,335	$125K
76536		<1%	1,947	$125K
86140		<1%	21,318	$123K
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	<1%	18,062	$123K
86480		<1%	2,459	$123K
82728		<1%	9,522	$122K
Z7512		<1%	4,604	$120K
97750		<1%	2,920	$118K
X4100		<1%	2,391	$118K
96409		<1%	4,515	$117K
87505		<1%	868	$112K
X3922		<1%	2,319	$107K
J1644	Injection, heparin sodium, per 1000 units	<1%	19,897	$106K
92579		<1%	4,232	$106K
72080		<1%	3,950	$105K
85007		<1%	27,390	$101K
99000		<1%	25,041	$100K
71250		<1%	402	$98K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	15,683	$98K
82977		<1%	12,900	$96K
0250		<1%	11,765	$96K
86352		<1%	1,104	$95K
94010		<1%	6,118	$95K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	165	$95K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	5,428	$91K
96361	Intravenous infusion, hydration; each additional hour	<1%	3,948	$90K
84703		<1%	12,722	$87K
69210		<1%	6,460	$87K
X4112		<1%	4,568	$87K
Z5999		<1%	93	$86K
J9370	Vincristine sulfate, 1 mg	<1%	6,979	$85K
97165		<1%	2,134	$85K
0259		<1%	16,370	$84K
80061	Lipid panel	<1%	6,653	$83K
73610		<1%	3,162	$83K
87650		<1%	5,249	$81K
73080		<1%	2,558	$80K
X4102		<1%	1,666	$80K
74455		<1%	1,190	$79K
41899	Unlisted procedure, dentoalveolar structures	<1%	131	$77K
72170		<1%	3,673	$77K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,475	$77K
Z4302		<1%	5,347	$76K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	3,999	$76K
85045		<1%	18,298	$76K
81003		<1%	30,233	$76K
99284	Emergency room visit (serious)	<1%	5,108	$75K
G0390	Trauma response team associated with hospital critical care service	<1%	70	$75K
99221		<1%	1,786	$75K
X3926		<1%	2,455	$74K
83550		<1%	10,207	$74K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,577	$73K
86360		<1%	1,369	$72K
J2501	Injection, paricalcitol, 1 mcg	<1%	16,367	$71K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,597	$71K
73090		<1%	3,382	$69K
75561		<1%	237	$68K
99203	Doctor's office visit, new patient (routine)	<1%	1,503	$68K
87077		<1%	7,976	$68K
86353		<1%	181	$67K
87040		<1%	3,099	$64K
83519		<1%	3,485	$64K
70486		<1%	422	$63K
86923		<1%	1,742	$63K
84305		<1%	3,749	$63K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,483	$63K
88185		<1%	215	$63K
86356		<1%	2,022	$62K
87631		<1%	932	$61K
97803		<1%	1,399	$61K
82784		<1%	6,560	$60K
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,340	$59K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	1,710	$59K
92557		<1%	1,168	$59K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,683	$59K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	3,982	$57K
73590		<1%	2,639	$57K
92555		<1%	4,359	$55K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	47	$55K
92250		<1%	760	$54K
74018		<1%	2,724	$54K
86359		<1%	1,267	$54K
73630		<1%	2,133	$54K
85652		<1%	18,433	$53K
86922		<1%	1,130	$53K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,240	$53K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	5,778	$52K
0203		<1%	12	$52K
Z5918		<1%	2,354	$51K
73130		<1%	1,583	$51K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,851	$50K
86850		<1%	5,548	$50K
86160		<1%	2,212	$49K
83020		<1%	3,197	$48K
86355		<1%	1,752	$47K
82803		<1%	3,157	$47K
73562		<1%	1,724	$47K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	1,103	$47K
82330		<1%	3,351	$46K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,069	$45K
A4649	Surgical supply; miscellaneous	<1%	1,652	$44K
J3262	Injection, tocilizumab, 1 mg	<1%	173	$44K
T1024	Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter	<1%	1,752	$44K
86905		<1%	2,003	$43K
96040		<1%	837	$43K
94060		<1%	1,558	$42K
G0378	Hospital observation service, per hour	<1%	2,013	$42K
81001		<1%	11,980	$41K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,668	$41K
82670		<1%	2,458	$40K
82570		<1%	6,773	$40K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,621	$39K
77074		<1%	1,285	$39K
81229		<1%	178	$39K
12011		<1%	534	$38K
V5010	Assessment for hearing aid	<1%	501	$37K
86357		<1%	1,341	$37K
84403		<1%	3,407	$37K
0370		<1%	1,667	$36K
92588		<1%	500	$36K
84630		<1%	3,530	$35K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	785	$35K
99070		<1%	3,561	$35K
87186		<1%	4,363	$34K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	757	$34K
80299		<1%	1,719	$33K
84156		<1%	11,106	$32K
80306		<1%	1,638	$31K
83615		<1%	5,167	$31K
J9260	Injection, methotrexate sodium, 50 mg	<1%	3,856	$31K
99285	Emergency room visit (most serious)	<1%	57	$30K
74160		<1%	113	$30K
71555		<1%	90	$30K
83880		<1%	1,235	$30K
87533		<1%	629	$30K
73110		<1%	1,118	$29K
97010		<1%	429	$29K
86003		<1%	443	$29K
P9035	Platelets, pheresis, leukocytes reduced, each unit	<1%	40	$28K
82947		<1%	6,098	$27K
83690		<1%	4,058	$27K
75565		<1%	676	$27K
70310		<1%	3,455	$26K
84255		<1%	1,520	$26K
36593		<1%	746	$26K
73100		<1%	1,464	$26K
86317		<1%	506	$26K
86900		<1%	5,609	$25K
95811		<1%	76	$25K
74181		<1%	40	$25K
85610		<1%	5,987	$25K
86920		<1%	663	$24K
82610		<1%	1,533	$24K
Z5932		<1%	509	$24K
73521		<1%	669	$24K
86225		<1%	1,555	$24K
93296		<1%	504	$24K
84445		<1%	557	$24K
82397		<1%	1,167	$24K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	14	$23K
82652		<1%	1,301	$23K
73070		<1%	1,502	$23K
85730		<1%	3,750	$23K
86769		<1%	557	$22K
86901		<1%	5,607	$22K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	2,470	$22K
90686		<1%	1,103	$21K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,807	$21K
82043		<1%	3,170	$20K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	279	$20K
83516		<1%	1,505	$20K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	425	$20K
82542		<1%	784	$20K
80180		<1%	1,296	$20K
73140		<1%	1,330	$19K
87070		<1%	2,471	$19K
71045	Radiologic examination, chest; single view	<1%	830	$19K
86833		<1%	2,242	$18K
83002		<1%	2,511	$18K
88104		<1%	2,345	$18K
72040		<1%	570	$17K
72100		<1%	581	$17K
82157		<1%	775	$17K
84244		<1%	698	$17K
86832		<1%	2,039	$17K
84425		<1%	567	$17K
92060		<1%	1,962	$16K
84446		<1%	828	$16K
76881		<1%	238	$16K
81015		<1%	5,765	$16K
Z4314		<1%	588	$16K
73552		<1%	549	$16K
72081		<1%	698	$16K
83001		<1%	2,098	$16K
84590		<1%	975	$15K
Z5920		<1%	694	$15K
0002A		<1%	403	$15K
92570		<1%	800	$14K
0272		<1%	4,226	$14K
X4540		<1%	438	$14K
29125		<1%	1,139	$14K
83520		<1%	751	$14K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,961	$14K
0001A		<1%	383	$13K
83498		<1%	939	$13K
87590		<1%	1,083	$13K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	3,130	$12K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	171	$12K
72082		<1%	357	$12K
93356		<1%	253	$12K
93225		<1%	263	$12K
73000		<1%	467	$11K
86706		<1%	946	$11K
A0429	Emergency ambulance ride, basic life support	<1%	404	$11K
0420		<1%	409	$11K
80195		<1%	1,138	$11K
84478		<1%	1,626	$10K
12001		<1%	162	$10K
82105		<1%	656	$10K
84295		<1%	2,695	$10K
84207		<1%	637	$10K
84132		<1%	2,671	$10K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	192	$9K
88184		<1%	215	$9K
82010		<1%	784	$9K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	440	$9K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	626	$9K
82657		<1%	117	$9K
92556		<1%	680	$9K
70360		<1%	559	$9K
84484		<1%	822	$9K
84402		<1%	689	$9K
J1170	Injection, hydromorphone, up to 4 mg	<1%	350	$8K
96411		<1%	280	$8K
82024		<1%	682	$8K
S0302	Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)	<1%	422	$8K
92700		<1%	250	$8K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,183	$8K
82550		<1%	1,341	$8K
85014		<1%	3,611	$8K
90658		<1%	851	$8K
82785		<1%	635	$8K
95974		<1%	29	$7K
97116		<1%	277	$7K
0301		<1%	2,272	$7K
70355		<1%	867	$7K
76776		<1%	83	$7K
90656		<1%	417	$7K
84146		<1%	722	$7K
92550		<1%	550	$7K
73060		<1%	290	$7K
87340		<1%	570	$7K
88304		<1%	749	$7K
82533		<1%	310	$7K
92134		<1%	613	$6K
86341		<1%	318	$6K
77080		<1%	222	$6K
82525		<1%	579	$6K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	12	$6K
73560		<1%	224	$6K
Z7510		<1%	92	$5K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	74	$5K
73620		<1%	277	$5K
82379		<1%	281	$5K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	330	$5K
80201		<1%	301	$5K
95012		<1%	187	$5K
92133		<1%	420	$5K
92522		<1%	92	$5K
87205		<1%	1,251	$5K
74230		<1%	198	$5K
84520		<1%	911	$5K
77072		<1%	437	$4K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	267	$4K
Z7504		<1%	92	$4K
0251		<1%	1,342	$4K
82139		<1%	213	$4K
73030		<1%	138	$4K
87081		<1%	658	$4K
85347		<1%	605	$4K
X4522		<1%	13	$4K
81479	Unlisted molecular pathology procedure	<1%	12	$4K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	254	$4K
86803		<1%	225	$4K
93016		<1%	87	$4K
72070		<1%	116	$3K
86704		<1%	249	$3K
77334		<1%	18	$3K
83051		<1%	381	$3K
81243		<1%	61	$3K
70491		<1%	13	$3K
96415		<1%	79	$3K
0700		<1%	153	$3K
89051		<1%	1,816	$3K
Z4309		<1%	123	$3K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	167	$3K
93886		<1%	12	$3K
76825		<1%	41	$3K
76010		<1%	126	$3K
84550		<1%	784	$3K
82248		<1%	550	$3K
43760		<1%	68	$3K
86765		<1%	143	$3K
76827		<1%	54	$3K
93976		<1%	14	$3K
84681		<1%	137	$3K
70480		<1%	12	$3K
96112		<1%	16	$3K
84702		<1%	163	$3K
85379		<1%	265	$2K
54640		<1%	39	$2K
86592		<1%	172	$2K
76885		<1%	29	$2K
77336		<1%	47	$2K
97161		<1%	58	$2K
J9070	Cyclophosphamide, 100 mg	<1%	36	$2K
51701		<1%	45	$2K
84432		<1%	91	$2K
76512		<1%	56	$2K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	643	$2K
92504		<1%	175	$2K
87252		<1%	27	$2K
54161		<1%	52	$2K
99499		<1%	35	$2K
31575		<1%	52	$2K
82746		<1%	300	$2K
85246		<1%	111	$2K
83789		<1%	75	$2K
J2185	Injection, meropenem, 100 mg	<1%	29	$2K
71020		<1%	67	$2K
80164		<1%	112	$2K
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	1,368	$2K
85384		<1%	193	$2K
84480		<1%	106	$2K
00000		<1%	66	$2K
31231		<1%	108	$2K
86787		<1%	117	$2K
86645		<1%	116	$2K
85240		<1%	107	$2K
80354		<1%	269	$2K
0324		<1%	1,106	$2K
86999		<1%	118	$2K
86615		<1%	41	$2K
82634		<1%	52	$1K
0471		<1%	65	$1K
Z5930		<1%	39	$1K
84143		<1%	45	$1K
94761		<1%	76	$1K
82633		<1%	27	$1K
85245		<1%	74	$1K
80158		<1%	57	$1K
95970		<1%	28	$1K
82390		<1%	94	$1K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	125	$1K
94760		<1%	340	$1K
83993		<1%	76	$1K
49452		<1%	25	$1K
86644		<1%	99	$990.00
30300		<1%	12	$946.68
94681		<1%	12	$924.03
86376		<1%	93	$923.72
82607		<1%	166	$910.15
87529		<1%	14	$907.36
29105		<1%	24	$888.46
0424		<1%	49	$884.46
0306		<1%	3,292	$877.27
84436		<1%	112	$873.31
83655		<1%	109	$872.00
91200		<1%	55	$855.62
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	14	$850.00
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	204	$832.09
86774		<1%	49	$821.73
0410		<1%	1,238	$809.89
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	70	$807.50
86665		<1%	26	$800.16
J3475	Injection, magnesium sulfate, per 500 mg	<1%	48	$783.83
87075		<1%	174	$776.58
93041		<1%	95	$770.65
91065		<1%	116	$765.76
86308		<1%	140	$760.14
82626		<1%	42	$756.00
97810		<1%	176	$729.42
89050		<1%	527	$703.86
99366		<1%	65	$696.31
99215	Doctor's office visit, returning patient (complex)	<1%	23	$693.71
86039		<1%	88	$686.13
94645		<1%	37	$682.16
86762		<1%	57	$678.23
86255		<1%	24	$671.31
86337		<1%	66	$660.00
86735		<1%	52	$640.83
A0422	Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation	<1%	45	$631.39
87449		<1%	46	$631.20
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	15	$628.20
96900		<1%	61	$620.70
99244	Office or other outpatient consultation, moderate to high complexity	<1%	34	$620.01
64642		<1%	41	$615.00
87305		<1%	68	$585.12
76140		<1%	34	$583.18
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	14	$577.75
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	67	$574.03
87116		<1%	40	$563.76
36415	Collection of venous blood by venipuncture	<1%	499	$554.91
29280		<1%	46	$549.70
82310		<1%	75	$547.50
76000		<1%	30	$547.39
85247		<1%	29	$543.63
82725		<1%	27	$509.22
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	145	$501.23
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	63	$494.67
92626		<1%	21	$464.24
99072		<1%	1,901	$445.50
93280		<1%	15	$436.95
10060		<1%	26	$436.81
80230		<1%	14	$432.04
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	16	$431.20
64643		<1%	25	$375.00
80177		<1%	28	$366.24
86708		<1%	25	$351.00
86800		<1%	24	$350.26
82523		<1%	13	$333.96
82085		<1%	29	$333.00
83919		<1%	14	$326.34
95874		<1%	40	$319.20
82140		<1%	19	$313.69
84144		<1%	26	$312.00
T1001	Nursing assessment / evaluation	<1%	28	$304.62
84479		<1%	40	$295.43
0434		<1%	28	$288.79
86364		<1%	27	$276.84
0310		<1%	516	$258.30
97164		<1%	12	$254.45
0300		<1%	2,346	$251.84
73120		<1%	16	$246.73
J1071	Injection, testosterone cypionate, 1 mg	<1%	102	$239.90
0320		<1%	831	$237.47
92083		<1%	27	$231.29
92132		<1%	15	$219.57
29130		<1%	26	$215.93
84585		<1%	12	$210.84
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	18	$204.18
11900		<1%	29	$184.02
99214	Doctor's office visit, returning patient (more involved)	<1%	20	$179.33
0305		<1%	1,978	$178.80
73600		<1%	12	$169.06
82747		<1%	28	$168.00
80329		<1%	81	$167.60
86709		<1%	13	$165.88
80076		<1%	28	$162.04
J7050	Infusion, normal saline solution, 250 cc	<1%	33	$159.98
0637		<1%	43	$159.41
51798		<1%	16	$158.18
83150		<1%	12	$156.96
29515		<1%	29	$135.66
51741		<1%	16	$131.27
92583		<1%	208	$116.74
87045		<1%	12	$104.74
87184		<1%	15	$104.39
83525		<1%	12	$91.20
J9100	Injection, cytarabine, 100 mg	<1%	31	$88.11
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	27	$87.74
84481		<1%	12	$81.60
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	14	$72.66
0271		<1%	856	$48.12
84460		<1%	12	$46.78
87046		<1%	12	$43.65
70300		<1%	26	$43.57
82565		<1%	13	$40.05
99001		<1%	52	$36.63
87181		<1%	12	$35.89
97014		<1%	364	$27.86
85018		<1%	63	$23.56
0307		<1%	830	$9.16
0302		<1%	1,307	$5.97
0730		0%	191	$0.00
0402		0%	638	$0.00
0483		0%	15	$0.00
0351		0%	43	$0.00
0412		0%	27	$0.00
0309		0%	42	$0.00
0352		0%	71	$0.00
0740		0%	15	$0.00
0440		0%	13	$0.00
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	0%	48	$0.00
0771		0%	22	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLIEBERENZ, MAX (SR.VP/CFO)

Same official

Other billing entities under LIEBERENZ, MAX

Full network →

Provider	Location	Paid
Children's Hospital Los Angeles	Los Angeles, CA	$8.17M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.